Pharmaceutical interventions and factors associated with their acceptance in intensive care units in Brazil
DOI:
https://doi.org/10.30827/ars.v64i3.27249Keywords:
Drug Therapy, Pharmaceutical Care, Intensive Care UnitsAbstract
Objective: The purpose of this study is to evaluate the pharmaceutical interventions (PI) performed in PRM and the factors associated with their acceptance.
Method: This is a descriptive and cross-sectional study that analyzed PIs performed on adult patients from two ICUs in Fortaleza, Brazil, in 2019. PIs were analyzed in the categories quantity of drug and pharmacological strategy, using the classification proposed by Sabater et al. The drugs were also classified by the Anatomical, Therapeutic, and Chemical Classification System and by the High Surveillance Drugs (FAV) classification.
Results: 305 patients were included, most of them male (55.1 %), elderly (52.8 %) and treated in the surgical ICU (51.4 %). 1,317 PIs were analyzed and 88.0 % were accepted, being to replace one or more drugs (28.0 %), to add one or more drugs (27.7 %) and to change the dose (24.8 %) the most frequent types. The most prevalent therapeutic class was anti-infectives for systemic use (24.1 %) and AVFs were involved in 21.7 % of the PIs. An association was observed between PIs accepted and admission to the clinical ICU (p<0.0001), AVF (p=0.0013), substitution of one or more drugs (p=0.0062) and the class of blood substitutes and perfusion solutions. (p= 0.0187).
Conclusions: A high number of PIs were performed and accepted, which reinforces the importance of the pharmacist in the review of medical prescriptions in the ICU.
Downloads
References
Donovan AL, Aldrich JM, Gross AK, Barchas DM, Thornton KC, Schell-Chaple HM, et al. University of California, San Francisco Critical Care Innovations Group. Interprofessional Care and Teamwork in the ICU. Crit Care Med. 2018;46(6):980-90. doi: 10.1097/CCM.0000000000003067.
Cardinal LS, Matos VT, Resende GM, Toffoli-Kadri MC. Characterization of drug prescriptions in an adult intensive care unit. Rev Bras Ter. intensiva. 2012; 24(2):151-6.
MacLaren R, Devlin JW. The Bedside Critical Care Pharmacist: A Mandatory ICU Team Member Essential for Patient Care. Crit Care Med. 2019;47(9):1276-8. doi: 10.1097/CCM.0000000000003888.
Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy. Pharmacotherapy. 2000;20:1400–6.
Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Resolução RDC Nº 7, de 24 de fevereiro de 2010. Dispõe sobre os requisitos mínimos para funcionamento de Unidades de Terapia Intensiva e dá outras providências. Diário Oficial da União, 2010; Secção 01, nº37.
Lee H, Ryu K, Sohn Y, Kim J, Suh GY, Kim E. Impact on Patient Outcomes of Pharmacist Participation in Multidisciplinary Critical Care Teams: A Systematic Review and Meta-Analysis. Crit Care Med. 2019; 47:1243–50. doi: 10.1097/CCM.0000000000003830.
MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008; 36:3184–9. doi: 10.1097/CCM.0b013e31818f2269.
Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008;36:427–33. doi: 10.1097/01.CCM.0000300275.63811.B3.
Wang T, Benedict N, Olsen KM, Luan R, Zhu X, Zhou N, et al. Effect of critical care pharmacist’s intervention on medication errors: a systematic review and meta-analysis of observational studies. J Crit Care. 2015;30:1101-6. doi: 10.1016/j.jcrc.2015.06.018.
Fideles GMA, Neto JMA, Peixoto Júnior AA, Neto PJS, Tonete TL, Silva JEG, et al. Recomendações farmacêuticas em unidade de terapia intensiva: três anos de atividades clínicas. Rev. bras. ter. intensiva. 2015;27(2):149-54. doi: 10.5935/0103-507X.20150026.
Lat I, Paciullo C, Daley MJ, MacLaren R, Bolesta S, McCann J, et al. Position Paper on Critical Care Pharmacy Services: 2020 Update. Crit Care Med. 2020 ;48(9):e813-e834. doi: 10.1097/CCM.0000000000004437.
Conselho Federal de Farmácia (CFF). Resolução CFF Nº 585 de 29 de agosto de 2013. Regulamenta as atribuições clínicas do farmacêutico e dá outras providências [Internet]. Brasília: CFF; 2013.
Shulman R, McKenzie CA, Landa J, Bourne RS, Jones A, Borthwick M, et al. PROTECTED-UK Group: Pharmacist’s review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK). J Crit Care 2015; 30:808–13. doi: 10.1016/j.jcrc.2015.04.008.
Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267–270. doi: 10.1001/jama.282.3.267. 39.
Sabater D, Fernandez-Llimos F, Parras M, Faus MJ. Tipos de intervenciones farmacéuticas en seguimiento farmacoterapéutico. Seguimiento Farmacoterapéutico. 2005;3(2):90-7.
World Health Organization. The anatomical therapeutic chemical classification system with defined daily doses (ATC/DDD). Norway: WHO. 2006. Available in . Accessed 01 Jan 2018.
Instituto para Práticas Seguras no Uso de Medicamentos. Medicamentos Potencialmente Perigosos de Uso Hospitalar e Ambulatorial - Listas Atualizadas 2015. Boletim ISMP Brasil. 2015; 4(3). Available in<http://www.ismp-brasil.org/site/wp-content/uploads/2015/12/V4N3.pdf>. Accessed 12 jun 2022.
Brasil. Lei n° 10.741, de 1º de outubro de 2003. Dispõe sobre o Estatuto do Idoso e dá outras providências. Diário Oficial da União, 3 out. 2003. Available in < http://www.planalto.gov.br/ccivil_03/leis/2003/l10.741.htm> Accessed 25 May 2022.
Maciel EC, Borges RP, Portela AS. Pharmaceutical actuation in intensive care units: contributions to rational use of drugs. Rev Bras Farm Hosp Serv Saude. 2019;10(4):0429. doi: 10.30968/rbfhss.2019.104.0429.
Klopotowska JE, Kuiper R, van Kan HJ, de Pont AC, Dijkgraaf MG, Lie-A-Huen L, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Critical Care. 2010;14(5):174. doi: 10.1186/cc9278.
Reis WC, Scopel CT, Correr CJ, Andrzejevski VM. Analysis of clinical pharma- cist interventions in a tertiary teaching hospital in Brazil. Einstein. 2013;11(2):190-6. doi: 10.1590/S1679-45082013000200010.
Dias D, Wiese LPL, Pereira EM, Fernandes FM. Evaluation of pharmaceutical clinical interventions in the ICU of a public hospital of Santa Catarina. Rev Bras Farm Hosp Serv Saude. 2019;9(3)1-5. doi: 10.30968/rbfhss.2018.093.005.
Bourne RS, Choo CL. Pharmacist proactive medication recommendations using electronic documentation in a UK general critical care unit. Int J Clin Pharm. 2012;34:351-7. doi: 10.1007/s11096-012-9613-7.
Sereno MTF, Serrano RP, Díaz-Miguel RO, González MCE, Álvarez HAH, Checa AA, et al. Pharmacist adscription to intensive care: Generating synergies. Med Intensiva. 2018;42(9):534-40. doi: 10.1016/j.medin.2018.02.006.
Al-Dorzi HM, Eissa AT, Khan RM, Harbi SAA, Aldabbagh T, Arabi YM. Dosing errors of empirical antibiotics in critically ill patients with severe sepsis or septic shock: A prospective observational study. Int j healthc sci. 2019;13(4):48-55.
Silva CDR, Silva Júnior M. Strategies for appropriate antibiotic use in intensive care unit. Einstein. 2015;13(3):448-53. doi: 10.1590/S1679-45082015RW3145.
Parente DM, Morton J. Role of the Pharmacist in Antimicrobial Stewardship. Med Clin North Am. 2018;102(5):929-36. doi: 10.1016/j.mcna.2018.05.009.
Miarons M, Marín S, Amenós I, Campins L, Rovira M, Daza M. Pharmaceutical interventions in the emergency department: cost-effectiveness and cost-benefit analysis. Eur J Hosp Pharm. 2021;28(3):133-8. doi: 10.1136/ejhpharm-2019-002067.
Pearson DJ, Sharma A, Lospinoso JA, Morris MJ, McCann ET. Effects of Electrolyte Replacement Protocol Implementation in a Medical Intensive Care Unit. J Intensive Care Med. 2018;33(10):574-81. doi: 10.1177/0885066616679593.
Cajanding JMR. Administering and monitoring high-alert medications in acute care. Nurs Stand. 2017;31(47)42–52.doi: 10.7748/ns.2017.e10849.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ana Vitória Martins de Oliveira, Elana Figueiredo Chaves, Amanda Mota Conceição, Liana Moreira Magalhães, Breno Queiroz de Araújo, Cinthya Cavalcante de Andrade, José Martins de Alcântara Neto, Alene Barros de Oliveira
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
